These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 11060232)
1. Early myotome specification regulates PDGFA expression and axial skeleton development. Tallquist MD; Weismann KE; Hellström M; Soriano P Development; 2000 Dec; 127(23):5059-70. PubMed ID: 11060232 [TBL] [Abstract][Full Text] [Related]
2. Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite. Henderson DJ; Conway SJ; Copp AJ Dev Biol; 1999 May; 209(1):143-58. PubMed ID: 10208749 [TBL] [Abstract][Full Text] [Related]
4. Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Kablar B; Krastel K; Tajbakhsh S; Rudnicki MA Dev Biol; 2003 Jun; 258(2):307-18. PubMed ID: 12798290 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of epaxial and hypaxial muscle development by paraxis. Wilson-Rawls J; Hurt CR; Parsons SM; Rawls A Development; 1999 Dec; 126(23):5217-29. PubMed ID: 10556048 [TBL] [Abstract][Full Text] [Related]
6. The early epaxial enhancer is essential for the initial expression of the skeletal muscle determination gene Myf5 but not for subsequent, multiple phases of somitic myogenesis. Teboul L; Hadchouel J; Daubas P; Summerbell D; Buckingham M; Rigby PW Development; 2002 Oct; 129(19):4571-80. PubMed ID: 12223413 [TBL] [Abstract][Full Text] [Related]
7. Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Gustafsson MK; Pan H; Pinney DF; Liu Y; Lewandowski A; Epstein DJ; Emerson CP Genes Dev; 2002 Jan; 16(1):114-26. PubMed ID: 11782449 [TBL] [Abstract][Full Text] [Related]
8. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. Valdez MR; Richardson JA; Klein WH; Olson EN Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423 [TBL] [Abstract][Full Text] [Related]
9. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Wang Y; Jaenisch R Development; 1997 Jul; 124(13):2507-13. PubMed ID: 9216993 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis of epaxial myotome in Danforth's short-tail (Sd) mice in somites that form following notochord degeneration. Asakura A; Tapscott SJ Dev Biol; 1998 Nov; 203(2):276-89. PubMed ID: 9808779 [TBL] [Abstract][Full Text] [Related]
11. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Tajbakhsh S; Borello U; Vivarelli E; Kelly R; Papkoff J; Duprez D; Buckingham M; Cossu G Development; 1998 Nov; 125(21):4155-62. PubMed ID: 9753670 [TBL] [Abstract][Full Text] [Related]
12. Six and Eya expression during human somitogenesis and MyoD gene family activation. Fougerousse F; Durand M; Lopez S; Suel L; Demignon J; Thornton C; Ozaki H; Kawakami K; Barbet P; Beckmann JS; Maire P J Muscle Res Cell Motil; 2002; 23(3):255-64. PubMed ID: 12500905 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of interactions between the somitic muscle, cartilage and tendon cell lineages during mouse development. Brent AE; Braun T; Tabin CJ Development; 2005 Feb; 132(3):515-28. PubMed ID: 15634692 [TBL] [Abstract][Full Text] [Related]
14. [Early stages of myogenesis as seen through the action of the myf-5 gene]. Buckingham M C R Seances Soc Biol Fil; 1997; 191(1):43-54. PubMed ID: 9181127 [TBL] [Abstract][Full Text] [Related]
15. Expression of the myogenic regulatory factor Mrf4 precedes or is contemporaneous with that of Myf5 in the somitic bud. Summerbell D; Halai C; Rigby PW Mech Dev; 2002 Sep; 117(1-2):331-5. PubMed ID: 12204280 [TBL] [Abstract][Full Text] [Related]
16. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Pownall ME; Gustafsson MK; Emerson CP Annu Rev Cell Dev Biol; 2002; 18():747-83. PubMed ID: 12142270 [TBL] [Abstract][Full Text] [Related]
17. Myf5 is a novel early axonal marker in the mouse brain and is subjected to post-transcriptional regulation in neurons. Daubas P; Tajbakhsh S; Hadchouel J; Primig M; Buckingham M Development; 2000 Jan; 127(2):319-31. PubMed ID: 10603349 [TBL] [Abstract][Full Text] [Related]
18. Myf5 expression in somites and limb buds of mouse embryos is controlled by two distinct distal enhancer activities. Buchberger A; Nomokonova N; Arnold HH Development; 2003 Jul; 130(14):3297-307. PubMed ID: 12783799 [TBL] [Abstract][Full Text] [Related]
19. Distinct signal/response mechanisms regulate pax1 and QmyoD activation in sclerotomal and myotomal lineages of quail somites. Borycki AG; Strunk KE; Savary R; Emerson CP Dev Biol; 1997 May; 185(2):185-200. PubMed ID: 9187082 [TBL] [Abstract][Full Text] [Related]
20. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Wang Y; Schnegelsberg PN; Dausman J; Jaenisch R Nature; 1996 Feb; 379(6568):823-5. PubMed ID: 8587605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]